296 results found for '搜索引擎怎么开通,http tw.yahoo.com,必应输入法win10用不了咨询QQ:605350014'.
Countdown to 2030: Stronger alignment for country impact
News | 23 May 2024
...in 69 countries. Country case studies in the report, illustrate how the commitment to stronger collaboration is being translated into reality at country level. This fifth progress report amplifies countries’...
Unitaid renews call for clear access strategy after positive results from Gilead’s PURPOSE 2 lenacapavir trial
News | 13 September 2024
...of research have yet to deliver an effective vaccine. Beyond prevention, it also holds promise for long-acting HIV treatment, pending further evidence on suitable combination therapies. Communities and countries most...
Ahead of World TB Day, Unitaid and FIND welcome WHO resources to accelerate access to faster, more accurate tests for drug-resistant tuberculosis
News | 21 March 2024
...Hervé Verhoosel Head of Communications and Spokesperson, Unitaid M: +33 6 22 59 73 54 verhooselh@unitaid.who.int Sarah-Jane Loveday Director, Communications, UNFPA M: +41 79 431 62 44 media@finddx.org About Unitaid...
Overlooked No More: Access to TB Innovations for Children and Pregnant Women is a Must
News | 19 March 2024
...toxic treatment options for all people with drug-resistant TB, including children, pregnant women and people with common co-morbidities. If recommended by WHO, four new all-oral regimens for multidrug-resistant (MDR) TB...
Unitaid applauds France’s steadfast commitment to sustainable global health interventions
News | 21 June 2024
At the Global Forum for Vaccine Sovereignty and Innovation held in Paris on 20 June, French President Emanuel Macron reconfirmed his country’s commitment to the innovative financing model that helped...
WHO recommendations, supported by Unitaid clinical trials, now allow for better treatment for all people with drug-resistant TB, including children and pregnant women
News | 23 August 2024
...IRD support local drug-resistant TB treatment activities. Each experimental regimen included at least one new drug combined with up to four companion drugs. The control regimen followed the local standard...
New Child-Friendly Formulation of Rifapentine for Short Course Tuberculosis Prevention Treatment Now Available as Unitaid and IMPAACT4TB Launch an Early Market Access Vehicle
News | 11 December 2023
...more information and media requests: Hervé Verhoosel Head of Communications and Spokesperson M: +33 6 22 59 73 54 verhooselh@unitaid.who.int Kyle Wilkinson, Communications Officer +41 79 445 17 45 wilkinsonk@unitaid.who.int...
Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options
News | 15 November 2023
...treatment regimens would empower clinicians to offer shortened MDR-TB treatment regardless of age, pregnancy, and comorbidities that are common among people with MDR-TB. In addition, the trial supports the use...
Partners announce reduced price for patient-friendly tuberculosis preventive treatments
News | 01 August 2022
...complete the full treatment cycle. A 2021 study showed that 90 percent of patients prescribed 3HP completed treatment compared to 50 percent of patients prescribed isoniazid alone[1]. Access to TPT...
New preventive treatment for children cuts the risk of drug-resistant tuberculosis by more than half, in first-ever study of its kind
News | 16 November 2023
...yesterday, as Unitaid-funded endTB clinical trial announced four new, all-oral, shortened MDR-TB treatment regimens that, if recommended, could be suitable for all populations regardless of age, pregnancy and common comorbidities....